| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b6d6b0a9721d7b7ca7d5f368df0f3658
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_381b4dc82437a24c05bf2ab88f573c56 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7076
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-215
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7076 |
| filingDate |
2005-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d9315ec20c7f79382e4a21b8d0ad4a69 |
| publicationDate |
2020-02-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
BR-PI0517132-B1 |
| titleOfInvention |
Use of cladribine for the preparation of a pharmaceutical formulation for the treatment of multiple sclerosis |
| abstract |
cladribine regimen for the treatment of multiple sclerosis. refers to the use of cladribine for the preparation of a pharmaceutical formulation for the treatment of multiple sclerosis, especially remitting-recurrent multiple sclerosis or premature secondary progressive multiple sclerosis, characterized by the fact that the preparation must be orally administered and characterized by the fact that new treatments are possible. |
| priorityDate |
2004-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |